Global market valuation was derived through revenue mapping and installed base analysis. The methodology included:
Identification of 55+ key manufacturers, OEM-certified refurbishment divisions, and independent refurbishers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Product mapping across medical imaging equipment (MRI, CT scanners, ultrasound, X-ray, nuclear medicine/PET-CT), operating room & surgical equipment (anesthesia machines, electrosurgical units, surgical microscopes), patient monitoring devices, cardiovascular equipment, neurology systems, and endoscopy devices
Analysis of reported and modeled annual revenues specific to refurbished/refurbishment service portfolios, including trade-in cycles and remarketing revenues
Coverage of OEM refurbishment programs and major independent refurbishers representing 72-76% of global market share in 2024
Extrapolation using bottom-up (installed base decommissioning rates × refurbishment conversion rates × ASP by modality and country) and top-down (manufacturer/refurbisher revenue validation) approaches to derive segment-specific valuations and regional market sizes
Incorporation of equipment age analytics (7-12 year primary lifecycle extension data) and hospital capital expenditure budget allocation trends for pre-owned medical technology
Data Triangulation & Validation
Market estimates were triangulated through:
Cross-referencing primary interview insights against secondary regulatory filing data and industry association statistics
Validation of average selling price (ASP) data across OEM-certified refurbishment programs and independent third-party refurbishers
Calibration against reported hospital procurement budgets for diagnostic imaging equipment and capital equipment lifecycle management surveys
Verification of refurbishment volume estimates against IEC 63077 certification database trends and notified body conformity assessment volumes under EU MDR Article 17
Quality assurance through multi-source confirmation of market sizing variables including equipment deinstallation forecasts, parts availability indices, and secondary market trade flows
FDA Final Guidance on "Remanufacturing of Medical Devices" (May 2024) distinguishing remanufacturing from servicing activities
EU MDR (EU) 2017/745 Article 17 and Common Specifications for reprocessing of single-use devices; European Commission Implementation Reports (2024)
Health Canada Medical Devices Regulations (SOR/98-282) provisions on refurbishment and resale of Class II-IV devices
AAMI EQ56:2024 Standard for Medical Equipment Management Programs and refurbishment quality systems
MITA NEMA 1-2015 Good Refurbishment Practices for Medical Imaging Equipment
IEC 63077:2019 Good refurbishment practices for medical imaging equipment
ISO 13485:2016 Medical devices — Quality management systems — Requirements for regulatory purposes
WHO Technical Report Series: Global Model Regulatory Framework for Medical Devices (including refurbishment provisions)